# OnCo record fda018-adc (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/fda018-adc/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "fda018-adc" ;
  schema:name "FDA018-ADC"@en ;
  schema:alternateName "FDA018-Antibody-drug Conjugate"@en ;
  schema:description "FDA018-ADC is an experimental antibody-drug conjugate from Shanghai Fudan-Zhangjiang Bio-Pharmaceutical in phase 3 trials for triple-negative breast cancer, with its target not yet stated publicly."@en ;
  schema:url <https://onco.cc/drugs/fda018-adc/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=FDA018> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "ADC" ;
  onco:cancers <https://onco.cc/cancers/tnbc/> ;
  onco:institutions <https://onco.cc/institutions/fuscc/> ;
  onco:trials <https://onco.cc/trials/nct06519370/> .